C2N Diagnostics, a St Louis, Missouri-based testing company that is developing a blood test for Alzheimer’s disease, has raised $20 million from the GHR Foundation, an independent philanthropy. Click here to read more.
Everlywell, a digital health company offering access to at-home collection lab tests, was granted Emergency Use Authorization from the U.S. Food and Drug Administration for a Covid-19 at-home collection kit. Click here to read more.
Want to promote a webcast, podcast or virtual networking event to the life science and healthcare industry readership of MedCity News? Contact Mary Aikoriegie on MedCity’s sales team to promote your event in our virtual events section of the website and in our newsletters. Email Mary at [email protected].
Picture: akindo, Getty Images